NIH-funded research R01 grant

Understanding how bacteria build their cell walls

Official title: Structure and dynamics of bacterial cell wall synthases

Funded at Harvard Medical School · NIH-11021789 · Data updated 2026-11-12

This study is looking at how bacteria build their protective walls, which is really important for their survival, and by understanding the special proteins that help with this process, we hope to find new ways to create antibiotics that can fight bacterial infections.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionHarvard Medical School
NIH-funded
Lab location1 site (Boston, United States)
Project startDecember 13, 2024
Project endNovember 30, 2029
Funding year2025
Award (this year)$637,729
NIH project number1R01AI187524-01
Project IDNIH-11021789 on NIH RePORTER

Who could benefit from this research

Could help

Patients suffering from bacterial infections, particularly those resistant to current antibiotics, would be ideal candidates to benefit from this research.

Less likely to help

Patients with viral infections or non-bacterial conditions may not receive any benefit from this research.

What this research studies

This research investigates the molecular mechanisms that bacteria use to construct their cell walls, which are crucial for their survival. By examining specific enzymes involved in this process, the study aims to uncover how these enzymes are activated and regulated. Using advanced techniques like structural biology and single-molecule fluorescence, the research will provide insights into the dynamics of these enzymes and their interactions with other proteins. This knowledge could lead to the development of new antibiotics targeting these essential processes.

Why it matters

Potential benefit: If successful, this research could lead to the discovery of new antibiotics that effectively combat bacterial infections.

How similar studies have gone: Other research has shown success in targeting bacterial cell wall synthesis, indicating that this approach has potential for significant advancements in antibiotic development.

Where this research is happening

  • Harvard Medical School
    Boston, United States
    Active

Researchers

  • Principal investigator: Kruse, Andrew — Harvard Medical School
  • Study coordinator: Kruse, Andrew

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.